REG - Intelligent Ultrasnd - Exercise of Options and Total Voting Rights

Intelligent UltrasoundAnnouncement

27/12/2024 11:30

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20241227:nRSa4672Ra&default-theme=true

RNS Number : 4672R  Intelligent Ultrasound Group PLC  27 December 2024

27 December 2024

 

 

Intelligent Ultrasound Group plc

("Intelligent Ultrasound" or the "Group" or the "Company")

Exercise of Options, Total Voting Rights and Rule 2.9 Announcement

 

Intelligent Ultrasound Group plc (AIM: IUG), the ultrasound simulation and
education company, announces that it has issued, conditional on admission,
3,823,182 new ordinary shares of 1 pence each in the capital of the Company
("Ordinary Shares"), pursuant to the exercise of share options.

The new Ordinary Shares will rank pari passu with the existing Ordinary Shares
in issue and application has been made for the new Ordinary Shares to be
admitted to trading on the AIM Market of the London Stock Exchange
("Admission"). Admission is expected to occur, and dealings in the new
Ordinary Shares commence, at 8:00 a.m. on 31 December 2024.

Rule 2.9 Announcement and Total Voting Rights

Following Admission, in accordance with Rule 2.9 of the City Code on Takeovers
and Mergers (the "Code"), the Company will have 331,013,103 Ordinary Shares in
issue. This figure of 331,013,103 may be used by shareholders as the
denominator for the calculations by which they will determine if they are
required to notify their interest in, or a change of their interest in, the
Company under the FCA's Disclosure Guidance and Transparency Rules.

 

ENDS

 

For further information, please contact:

 Intelligent Ultrasound                                                    +44 (0)29 2075 6534
 Stuart Gall, CEO

 Helen Jones, CFO

 Cavendish Capital Markets Limited (Rule 3 Independent Financial Adviser,
 Nominated Adviser and Corporate Broker to Intelligent Ultrasound)
 Giles Balleny                                                             +44 (0) 20 7220 0500

 Henrik Persson

 Hamish Waller

 Cardew Group (PR Adviser to Intelligent Ultrasound)
 Alison Connolly                                                           +44 (0) 7587 453955
 Emma Pascoe-Watson                                                        +44 (0) 7774 620415
 Jessica Pilling                                                           +44 (0) 7918 584573

 

About Intelligent Ultrasound Group

Intelligent Ultrasound (AIM: IUG) is one of the world's leading ultrasound
simulation and education companies, specialising in real-time hi-fidelity
virtual reality simulation for the ultrasound training market. The
company's main products are the ScanTrainer obstetrics and gynaecology
training simulator, the HeartWorks echocardiography training simulator,
the BodyWorks Eve Point of Care and Emergency Medicine training simulator,
the new BabyWorks Neonate and Paediatric training simulator
and NeedleTrainer, which teaches real-time ultrasound-guided needling. To
date over 1,800 simulators have been sold to over 800 medical institutions
around the world.

www.intelligentultrasound.com (http://www.intelligentultrasound.com/)

 

 This announcement does not constitute an offer to purchase any securities,
or an offer to sell or the solicitation of an offer to buy any securities, nor
shall there be any offer to purchase or sell securities in any jurisdiction in
which such offer, solicitation or sale would be unlawful. The release,
distribution or publication of this announcement in jurisdictions other than
the UK may be restricted by law and therefore any persons who are subject to
the laws of any jurisdiction other than the UK should inform themselves about
and observe any applicable requirements.

Disclosure requirements of the Code

Under Rule 8.3(a) of the Code, any person who is interested in 1% or more of
any class of relevant securities of an offeree company or of any securities
exchange offeror (being any offeror other than an offeror in respect of which
it has been announced that its offer is, or is likely to be, solely in cash)
must make an Opening Position Disclosure (as defined in the Code) following
the commencement of the offer period and, if later, following the announcement
in which any securities exchange offeror is first identified. An Opening
Position Disclosure must contain details of the person's interests and short
positions in, and rights to subscribe for, any relevant securities of each of
(i) the offeree company and (ii) any securities exchange offeror(s). An
Opening Position Disclosure by a person to whom Rule 8.3(a) applies must be
made by no later than 3.30 p.m. (London time) on the 10th business day
following the commencement of the offer period and, if appropriate, by no
later than 3.30 p.m. (London time) on the 10th business day following the
announcement in which any securities exchange offeror is first identified.
Relevant persons who deal in the relevant securities of the offeree company or
of a securities exchange offeror prior to the deadline for making an Opening
Position Disclosure must instead make a Dealing Disclosure (as defined in the
Code).

Under Rule 8.3(b) of the Code, any person who is, or becomes, interested in 1%
or more of any class of relevant securities of the offeree company or of any
securities exchange offeror must make a Dealing Disclosure if the person deals
in any relevant securities of the offeree company or of any securities
exchange offeror. A Dealing Disclosure must contain details of the dealing
concerned and of the person's interests and short positions in, and rights to
subscribe for, any relevant securities of each of (i) the offeree company and
(ii) any securities exchange offeror(s), save to the extent that these details
have previously been disclosed under Rule 8. A Dealing Disclosure by a person
to whom Rule 8.3(b) applies must be made by no later than 3.30 p.m. (London
time) on the business day following the date of the relevant dealing.

If two or more persons act together pursuant to an agreement or understanding,
whether formal or informal, to acquire or control an interest in relevant
securities of an offeree company or a securities exchange offeror, they will
be deemed to be a single person for the purpose of Rule 8.3.

Opening Position Disclosures must also be made by the offeree company and by
any offeror and Dealing Disclosures must also be made by the offeree company,
by any offeror and by any persons acting in concert with any of them (see
Rules 8.1, 8.2 and 8.4).

Details of the offeree and Bidder companies in respect of whose relevant
securities Opening Position Disclosures and Dealing Disclosures must be made
can be found in the Disclosure Table on the Takeover Panel's website at
www.thetakeoverpanel.org.uk, including details of the number of relevant
securities in issue, when the offer period commenced and when any Bidder was
first identified. You should contact the Panel's Market Surveillance Unit on
+44 (0)20 7638 0129 if you are in any doubt as to whether you are required to
make an Opening Position Disclosure or a Dealing Disclosure.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  IOEFEMFFWELSEEE